References
- Selwyn PA, Feingold AR, Hartel D, Schoenbaum EE, Alderman MH, Klein RS, Friedland GH. Increased risk of bacterial pneumonia in HIV-infected drug users without AIDS. AIDS 1988; 2: 267–272
- Garcia-Leoni ME, Moreno S, Cercenado E, Vicente T, Bouze E. Pneumococcal pneumonia in adult hospitalized patients infected with the human immunodeficiency virus. Arch Intern Med 1992; 152: 1808–1812
- Janoff EN, Breiman RF, Daley CL, Hopewell PC. Pneumococcal disease during HIV infection. Epidemiologic, clinical and immunologic perspectives. Ann Intern Med 1992; 117: 314–324
- Bukrinsky MI, Stanwick TL, Dempsey MP, Stevenson M. Quiescent T Lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 1991; 254: 423–426
- Virelizier JL. Cellular activation and human immunodeficiency virus infection. Current Opinion Immunol 1990; 2: 409–413
- Konradsen HB, Sørensen U BS, Henrichsen J. A modified enzyme-linked immunosorbent assay for measuring type-specific anti-pneumococcal capsular polysaccharide antibodies. J Immunol Method 1993; 164: 13–20
- Yerly S, Wunderli W, Wyler CA, Kaiser L, Hirschel B, Suter S, Perrin LH, Siegrist CA. Influenza immunization on HIV-1 infected patients does not increase HIV-1 viral load. AIDS 1994; 10: 1503–1504
- O'Brien WA, Ovcak H, Kalhor H, Mao SH, Zack JA. HIV-1 replication can be increased in blood from seropositive patients following influenza immunization. IX International Conference on AIDS, abstract PO-A12-0209. 1993. Berlin
- Ho DD. HIV-1 viraemia and influenza. Lancet 1992; 339: 1549
- Janoff EN, Douglas JM, Gabriel M, Blaser MJ, Davidson AJ, Cohn DL, Judson FN. Class-specific antibody response to pneumococcal capsular polysaccharides in men infected with human immunodeficiency virus type 1. J Infect Dis 1988; 158: 983–990